Availability of EpiPen® 0.15mg and 0.3mg Adrenaline Auto-Injectors
- 23 April 2020
- News
Mylan’s manufacturing partner Meridian Medical Technologies, a subsidiary of Pfizer that manufactures EpiPen®, had previously experienced manufacturing challenges which resulted in interruptions in the supply of EpiPen Jr 0.15mg and EpiPen 0.3mg Adrenaline Auto-Injectors (AAIs). Supply has stabilised further in the UK and there is good availability of both EpiPen Jr 0.15mg and EpiPen 0.3mg AAIs.
The prescription validation process previously applied is no longer in place and the limit of two pens per prescription has now been lifted.
Please read the full update here: EpiPen Supply UK Website Update
Prescribers
It is important that you follow MHRA advice and prescribe two Adrenaline Auto Injectors and ensure that the patient is taught how to administer the Adrenaline Auto Injector at the point of prescribing.
Pharmacists
It is important to ensure that the patient is taught how to administer the Adrenaline Auto Injector at the point of dispensing the Adrenaline Auto Injector.
In August 2019, the MHRA granted approval for Mylan UK to permanently extend the shelf life of EpiPen 0.3mg auto-injectors from 20 months to 24 months.
For AAIs already on the market, prior to the permanent extension of shelf life above, Mylan UK obtained approval from the MHRA to extend the use of specific lot (batch) numbers of EpiPen® 0.3mg auto?injectors, four months beyond the labelled expiry date. The affected lot numbers are listed in the table here.
